Zealand Pharma Current Ratio vs. Market Capitalization

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>ZP</div>
ZEAL -- Denmark Stock  

DKK 259.00  5.00  1.89%

The Drivers Module shows relationships between Zealand Pharma's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Zealand Pharma AS over time as well as its relative position and ranking within its peers. Check out Your Current Watchlist

Search Current Fundamental Trends

 
Refresh
Sales per Share is projected to rize to 1.46 this yearZealand Pharma Operating Income is quite stable at the moment as compared to the last year. The company current value of Operating Income is estimated at about 633.51 Million. Net Income Per Employee is projected to rize to about 3.8 M this year, although the value of Net Income will most likely fall to (508.2 M).

Zealand Pharma AS Market Capitalization vs. Current Ratio Fundamental Analysis

Zealand Pharma AS is rated second in current ratio category among related companies. It is rated second in market capitalization category among related companies creating about  1,729,729,730  of Market Capitalization per Current Ratio. . Zealand Pharma Current Ratio is quite stable at the moment as compared to the last year. The company current value of Current Ratio is estimated at about 5.18
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Zealand Pharma 
Current Ratio 
 = 
Current Asset 
Current Liabilities 
=
5.18 
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Zealand Pharma 
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
=
8.96 B
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Zealand Pharma AS is rated second in market capitalization category among related companies. Market capitalization of Biotechnology industry is at this time estimated at about 17.92 Billion. Zealand Pharma totals roughly 8.96 Billion in market capitalization claiming about 50% of stocks in Biotechnology industry.
Capitalization  Total debt  Workforce  Valuation  Revenue

Zealand Fundamental Comparison

Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page